Research workbench
Crystal structure of caspase-3 with inhibitor ac-itakd-cho
Analyse Crystal structure of caspase-3 with inhibitor ac-itakd-cho in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 7RNG
- Type
- protein
- Length
- 474 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Caspase-3 subunit P17; Caspase-3 subunit P12; Ac-itakd-cho
- UniProt
- P42574
- Pockets
- 1 · best druggability 0.65
Structure
x-ray diffraction · 3 distinct chains · 30% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, C | Caspase-3 subunit P17 | protein | 140 | 28% helix, 29% strand | P42574 |
| B, D | Caspase-3 subunit P12 | protein | 92 | 34% helix, 21% strand | P42574 |
| F, G | Ac-itakd-cho | protein | 5 | 0% helix, 60% strand | — |
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 297 | 0.65 | 0.81 | 38 | empty |
Interfaces
10 interfaces between chains.
- A–B · 2195 Ų buried · 36 hydrogen bonds · protein-protein
- C–D · 2155 Ų buried · 30 hydrogen bonds · protein-protein
- B–D · 1425 Ų buried · 18 hydrogen bonds · protein-protein
- B–F · 450 Ų buried · 10 hydrogen bonds · protein-protein
- A–D · 427 Ų buried · 11 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P42574
- Elsewhere: RCSB PDB 7RNG · PDBe 7RNG · UniProt P42574
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.